Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk

OBJECTIVES: To reassess the safety and efficacy of once-weekly teriparatide 56.5 μg in osteoporosis patients with a high fracture risk. METHODS: This postmarketing observational study was conducted at 72 weeks according to the package insert. Of the 3573 Japanese osteoporosis patients in the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Ifuku, Emiko, Yoshimura, Takeshi, Uzawa, Toyonobu, Hokonohara, Tadami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626839/
https://www.ncbi.nlm.nih.gov/pubmed/31338434
http://dx.doi.org/10.1016/j.afos.2019.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626839/
https://www.ncbi.nlm.nih.gov/pubmed/31338434
http://dx.doi.org/10.1016/j.afos.2019.06.002

Ejemplares similares